StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Hologic (HOLX) PT Lowered to $43 at Needham & Company; 'Ugly Write-Down for Aesthetics Business'
May 3, 2018 6:43 AM
Needham & Company lowered its price target on Hologic (NASDAQ: HOLX) to $43.00 (from $50.00) while maintaining a Buy rating.Analyst ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst EPS Change
Analyst EPS View
Analyst PT Change
Next Articles
Hologic (HOLX) PT Lowered to $40 at RBC Capital
May 3, 2018 8:47 AM
Hologic (HOLX) PT Lowered to $40 at Stifel
May 3, 2018 7:38 AM
Hologic (HOLX) PT Lowered to $40.50 at Evercore ISI
May 3, 2018 7:37 AM
Hologic (HOLX) PT Lowered to $48 at Piper Jaffray
May 3, 2018 6:25 AM
Leerink Partners Downgrades Hologic (HOLX) to Market Perform
May 3, 2018 6:19 AM
Hologic (HOLX) PT Lowered to $42 at Cowen
May 3, 2018 6:15 AM
Canaccord Genuity Downgrades Hologic (HOLX) to Hold
May 3, 2018 4:40 AM
Hologic (HOLX) PT Lowered to $50 at Barclays
May 3, 2018 3:50 AM
Hologic (HOLX) PT Lowered to $42 at Deutsche Bank
May 3, 2018 3:23 AM
Hologic (HOLX) Reports In-Line Q2 EPS; Lowers Rev Guidance, Maintains EPS
May 2, 2018 4:05 PM
Hologic Announces Financial Results for Second Quarter of Fiscal 2018
May 2, 2018 4:01 PM
